NHS Framework Agreement, Branded Medicines for London and South of England

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
1B
Sector
HEALTH
Published
17 Sep 2021
Delivery
not specified
Deadline
n/a

Related Terms

Location

London: Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points

Geochart for 1 buyers and 114 suppliers

1 buyer

42 suppliers

Description

NHS Framework Agreement, Branded Medicines for London and South of England and NHS Framework for the Midlands & East and North of England Regions – Bevacizumab.

Lot Division

1 CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B
  • Value: 349M

CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B.Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 Months
2 CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche
  • Value: 164M

CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
3 CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A
  • Value: 108M

CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A.Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
4 CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B
  • Value: 220M

CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B.Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
5 CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche
  • Value: 272M

CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche.Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
6 CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab
  • Value: 4M

CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions – Bevacizumab

Award Detail

1 Drreddys Laboratories (Beverley)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-1
2 Accord (Devon)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-2
3 Techdow Pharma England (Guildford)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-3
4 Ul Global Pharma (Hertfordshire)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-4
5 Biogen (Maidenhead)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-5
6 Merck Sharpe & Dohme (London)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-6
7 Bayer (Reading)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-7
8 Napp Pharmaceuticals (Cambridge)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-8
9 Novo Nordisk (Gatwick)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-9
10 Daiichi Sankyo (Uxbridge)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-10
11 Teva (Castleford)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-11
12 Pfizer (Kent)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-12
13 Roche Products (Garden City)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-13
14 Mylan (Barnet)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-14
15 Sandoz (Camberley)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-15
16 Celltrion Healthcare (Slough)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-16
17 Merck Serono (Feltham)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-17
18 Bristol Myers Squibb (Uxbridge)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-18
19 Eli Lilly (Basingstoke)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-19
20 Takeda (London)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-20
21 Ferring Pharmaceuticals (West Drayton)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-21
22 Aventis Pharma (Reading)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-22
23 Tetris Pharma (Northampton)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-23
24 Ipsen (Slough)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-24
25 Profile Pharma (Chichester)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-25
26 CST Pharma (Walsall)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-26
27 Gilead Sciences (Holborn)
  • NHS Framework LONDON Branded Medicines - Tranche B
  • Reference: 023223-2021-cm/phr/20/5598-27
28 Drreddys Laboratories (Beverley)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-28
29 Accord (Devon)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-29
30 Techdow Pharma England (Guildford)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-30
31 Ul Global Pharma (Hertfordshire)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-31
32 Biogen (Maidenhead)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-32
33 Merck Sharpe & Dohme (London)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-33
34 Bayer (Reading)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-34
35 Napp Pharmaceuticals (Cambridge)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-35
36 Novo Nordisk (Gatwick)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-36
37 Daiichi Sankyo (Uxbridge)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-37
38 Teva (Castleford)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-38
39 Pfizer (Kent)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-39
40 Roche Products (Garden City)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-40
41 Mylan (Barnet)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-41
42 Sandoz (Camberley)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-42
43 Celltrion Healthcare (Slough)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-43
44 Merck Serono (Feltham)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-44
45 Bristol Myers Squibb (Uxbridge)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-45
46 Eli Lilly (Basingstoke)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-46
47 Takeda (London)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-47
48 Ferring Pharmaceuticals (West Drayton)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-48
49 Aventis Pharma (Reading)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-49
50 Tetris Pharma (Northampton)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-50
51 Ipsen (Slough)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-51
52 Profile Pharma (Chichester)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-52
53 CST Pharma (Walsall)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-53
54 Gilead Sciences (Holborn)
  • NHS Framework SOUTH of England - Tranche B
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598-54
55 Accord (Devon)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-55
56 Amgen (Cambridge)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-56
57 Thornton & Ross (Huddersfield)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-57
58 Merck Sharpe & Dohme (London)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-58
59 Zentiva Pharma (London)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-59
60 Napp Pharmaceuticals (Cambridge)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-60
61 Gedeon Richter (Maida Vale)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-61
62 Teva (Castleford)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-62
63 Pfizer (Kent)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-63
64 Roche Products (Garden City)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-64
65 Janssen Cilag (High Wycombe)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-65
66 Organon Pharmaceuticals (London)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-66
67 Celltrion Healthcare (Slough)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-67
68 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-68
69 Bristol Myers Squibb (Uxbridge)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-69
70 Eli Lilly (Basingstoke)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-70
71 Takeda (London)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-71
72 Astrazeneca (Luton)
  • NHS Framework LONDON Branded Medicines – Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598-72
73 Accord (Devon)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-73
74 Amgen (Cambridge)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-74
75 Napp Pharmaceuticals (Cambridge)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-75
76 Novo Nordisk (Gatwick)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-76
77 Teva (Castleford)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-77
78 Pfizer (Kent)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-78
79 Roche Products (Garden City)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-79
80 Janssen Cilag (High Wycombe)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-80
81 Allergan (Marlow)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-81
82 Sandoz (Camberley)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-82
83 Merck Serono (Feltham)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-83
84 Eli Lilly (Basingstoke)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-84
85 Vifor Pharma (London)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-85
86 Merz (Hemel Hempstead)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-86
87 Pharmacosmos (Reading)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-87
88 Ipsen (Slough)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-88
89 Morningside Pharmaeuticals (Northampton)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-89
90 Chugai (Chiswick)
  • NHS Framework SOUTH of England Tranche A
  • Reference: 023223-2021-cm/phr/20/5598/03-90
91 Thornton & Ross (Huddersfield)
  • NHS Framework Midlands & East and NofE – Bevacizumab
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598/06-91
92 Zentiva Pharma (London)
  • NHS Framework Midlands & East and NofE – Bevacizumab
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598/06-92
93 Pfizer (Kent)
  • NHS Framework Midlands & East and NofE – Bevacizumab
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598/06-93
94 Roche Products (Garden City)
  • NHS Framework Midlands & East and NofE – Bevacizumab
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598/06-94
95 Organon Pharmaceuticals (London)
  • NHS Framework Midlands & East and NofE – Bevacizumab
  • Reference: 023223-2021-fts/ojeu lot cm/phr/20/5598/06-95
96 Accord (Devon)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-96
97 Amgen (Cambridge)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-97
98 Thornton & Ross (Huddersfield)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-98
99 Merck Sharpe & Dohme (London)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-99
100 Zentiva Pharma (London)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-100
101 Napp Pharmaceuticals (Cambridge)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-101
102 Gedeon Richter (Maida Vale)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-102
103 Teva (Castleford)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-103
104 Pfizer (Kent)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-104
105 Roche Products (Garden City)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-105
106 Janssen Cilag (High Wycombe)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-106
107 Organon Pharmaceuticals (London)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-107
108 Celltrion Healthcare (Slough)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-108
109 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-109
110 Bristol Myers Squibb (Uxbridge)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-110
111 Eli Lilly (Basingstoke)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-111
112 Takeda (London)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-112
113 Astrazeneca (Luton)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-113
114 Ucb (Slough)
  • NHS Framework SOUTH of England Annual Tranche
  • Reference: 023223-2021-cm/phr/20/5598/05-114

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-02ac57
  • FTS 023223-2021

Domains